Forward Pharma A/S (FWP)

Forward Pharma AS Stock Analysis & Ratings

FWP Stock Chart & Stats

Day’s Range$5.43 - $5.56
52-Week Range$4.86 - $20.31
Previous Close$5.76
Average Volume (3M)8.97K
Market Cap$39.00M
P/E Ratio-20.2
Next EarningsApr 12, 2023
EPS ForecastN/A
Dividend YieldN/A
1Y Price TargetN/A
Smart Score3
EPS (TTM)-0.27

Forward Pharma AS News

Currently, no data available
Please return soon. This page is being updated.




P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.


Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Forward Pharma AS’s price range in the past 12 months?
Forward Pharma AS lowest stock price was $4.86 and its highest was $20.31 in the past 12 months.
    What is Forward Pharma AS’s market cap?
    Forward Pharma AS’s market cap is $39.00M.
      What is Forward Pharma AS’s price target?
      Currently, no data Available
      What do analysts say about Forward Pharma AS?
      Not enough analysts have published a price target to provide an average price target.
      When is Forward Pharma AS’s upcoming earnings report date?
      Forward Pharma AS’s upcoming earnings report date is Apr 12, 2023 which is in 329 days.
        How were Forward Pharma AS’s earnings last quarter?
        Forward Pharma AS released its earnings results on Apr 08, 2022. The company reported -$0.122 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.122.
          Is Forward Pharma AS overvalued?
          According to Wall Street analysts Forward Pharma AS’s price is currently Overvalued.
            Does Forward Pharma AS pay dividends?
            Forward Pharma AS pays a Notavailable dividend of $161.51 which represents an annual dividend yield of N/A. Forward Pharma AS’s last Notavailable dividend payment was on Sep 11, 2017. Forward Pharma AS’s upcoming ex-dividend date is Sep 12, 2017
              What is Forward Pharma AS’s EPS estimate?
              Forward Pharma AS’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Forward Pharma AS have?
              Forward Pharma AS has 7,090,000 shares outstanding.
                What happened to Forward Pharma AS’s price movement after its last earnings report?
                Forward Pharma AS reported an EPS of -$0.122 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.534%.
                  Which hedge fund is a major shareholder of Forward Pharma AS?
                  Currently, no hedge funds are holding shares in FWP


                  Forward Pharma AS Stock Analysis

                  Smart Score
                  Price Target
                  No data currently available
                  The Forward Pharma AS stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Forward Pharma A/S

                  Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 1, 2005 and is headquartered in Copenhagen, Denmark.

                  Similar Stocks
                  Price & Change
                  Sanofi-Aventis Sa

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis